Ruth Oratz

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.

Sandra Demaria, M Volm, Richard L. Shapiro et al. · PubMed · 2001 · 303 citations

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Howard S. Höchster, Leonard Liebes, James L. Speyer et al. · Journal of Clinical Oncology · 1994 · 165 citations

Radiation Therapy, Well-tolerated Regimen, Medicine +15

Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.

W. Fraser Symmans, Matthew Volm, Richard L. Shapiro et al. · PubMed · 2000 · 152 citations

Breast Oncology, Cancer Management, Pathology +16

Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast Cancer

Ruth Oratz, Dev Prosad Paul, Allen Lee Cohn et al. · Journal of Oncology Practice · 2007 · 105 citations · Full text

Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.

Jean‐Claude Bystryn, Anne Zeleniuch‐Jacquotte, Ruth Oratz et al. · PubMed · 2001 · 102 citations

Surgical Oncology, Immunology, Immunoediting +17